Abstract: MPA diameter from low-dose unenhanced multi-slice CT reliably predicts PHT, providing an important added clinical value from AC for SPECT MPI. 
Main pulmonary artery diameter from attenuation correction CT scans in cardiac SPECT accurately predicts pulmonary hypertension
Irene
INTRODUCTION
Pulmonary hypertension (PHT) is an important predictor of an adverse outcome in patients with known or suspected coronary artery disease 1 . Several findings of PHT have been reported in nuclear single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), such as flattening of the interventricular septum (D-shaped left ventricle), septal wall motion abnormalities/perfusion defect, and right ventricular (RV) enlargement or hypertrophy 2, 3 . Attenuation correction (AC) of MPI with x-ray-derived attenuation maps obtained from a single-slice computer tomography scanner (CT) device has been introduced in the last years 4 . However, transmission scans from single-slice CT scanners do not allow reliable interpretation of anatomic details. Recently, use of a high-end standalone CTscanner has been proposed to obtain AC maps for MPI 5 . These low-dose data sets from a 64-slice scanner yield an image quality allowing anatomic evaluation.
While contrast-enhanced chest CT scans provide reliable signs of PHT such as enlarged main pulmonary artery (MPA) diameter 6 , expanded RV outflow tract, and augmented distensibility of the MPA 7 , as well as increased ratio of MPA to aortic diameter 8 , the accuracy of unenhanced low-dose CT to reliably detect PHT from MPA diameter is not yet well validated.
The aim of this study was to identify the cut-off MPA diameter best predicting PHT from lowdose unenhanced multi-slice CT for AC of MPI.
MATERIALS AND METHODS

Patients
We retrospectively screened 183 consecutive patients referred for coronary artery disease assessment with SPECT MPI, until 100 patients were enrolled. To compare our results with the clinical gold standard for PHT and to have a study population with a high prevalence of PHT we applied the following inclusion criteria: first, transthoracic echocardiography within 6 months from SPECT MPI, documenting the right ventriculo-atrial (RV/RA) gradient in mm Hg. Second, a known or suspected pulmonary pathology such as bronchial carcinoma, dyspnea, PHT, chronic pulmonary embolism, chronic obstructive pulmonary disease, or emphysema.
The study protocol was approved by the institutional review board and written informed consent was obtained.
SPECT MPI Acquisition
SPECT MPI data acquisition was performed on a dualhead detector camera (Ventri, GE Healthcare), using a 1-day stress (0.14 mg/kg/min adenosine i.v. over 6 minutes, or dobutamine 10-40 lg/kg/min)/rest protocol with a dose of approximately 300 and 900 MBq of 99mTc tetrofosmin, respectively, as previously reported 9 . In brief, we acquired at 3⁰ rotation per stop, 180⁰ each head, and 
CT Scanning
All CT scans for AC were performed on a 64-slice CT on a LightSpeed VCT XT scanner (GE Healthcare) using prospective ECG-triggering (70% of the R-R interval) and the following scanning parameters: gantry rotation time 350 ms, 2.5 mm section thickness, 120 kV tube voltage, 200 mA effective tube current, resulting in an estimated mean applied radiation dose of 1.1 ± 0.1 mSv (range 0.9-1.4 mSv) 14 . Scanning was performed from the tracheal bifurcation to the diaphragm, in inspiration and with elevated arms. CT images were reconstructed at 2.5-mm slice thickness using a reconstruction algorithm with a 512 9 512 matrix. Reconstructed images were transferred to the external workstation for further analysis (AW 4.4, GE Healthcare).
CT Image Analysis
Two experienced radiologists, who were blinded to the results from echocardiography and the SPECT data, assessed the maximumMPA diameter as follows: on standard axial sections in a soft tissue 
Statistical Analysis
The optimal cut-off point for predicting PHT was determined using a receiver operator characteristic (ROC) curve for the MPA diameter and the body surface corrected MPA diameter from unenhanced CT, for the regional scores for septal stress perfusion defects as well as for the septal wall motion abnormalities. For the visually analyzed MPI SPECT signs such as D-shape and RV enlargement sensitivity, specificity, positive, and negative predictive values were calculated.
In addition, all five SPECT MPI criteria for PHT (septal stress perfusion defects/wall motion abnormalities, RV hypertrophy/enlargement and D-shape) and the MPA diameter were added up to a total score (0-6). ROC analysis was performed for these summed criteria. The optimal cut-off point for all ROC curves was determined using the Youden index (J value), calculated as the maximum of J = SN + SP -1, where SN is sensitivity and SP is specificity, for each cut-off volume 16 . Areas under the ROC curve 
RESULTS
Patient Characteristics
Patient characteristics are listed in Table 1 . From 100 enrolled patients with suspected or known pulmonary pathologies, 60 were referred for preoperative coronary artery disease assessment and in 40 patients the main reason for cardiac SPECT MPI was dyspnea. For further clinical information see Table   2 . In 72 patients stress examination was performed with 0.14 mg/kg/min adenosine i.v. without any complications. In 28 patients dobutamine stress was performed, due to known severe COPD.
In 2 patients a systemic lupus erythematosus was present, but none of them had an aneurysmal pulmonary artery. In 2 patients a a1-antitrypsin deficiency was known, one had no PHT, the second patient had a mild PHT (36 mm Hg pressure gradient) with moderate MPA dilatation of 32 mm.
CT and MPI Results
AUC for MPA diameter as predictor of PHT was 0.85 (with a 95% confidence interval 0.724-0.923, P <.001) with a resulting cut-off value of 30 mm using the Youden-Index, which yielded a sensitivity, specificity, positive (PPV), and negative predictive value (NPV) and accuracy of 78%, 91%, 83%, 88%, and 86%, respectively. Correction of the MPA diameter for the calculated body surface area resulted in a slight decrease of the AUC (0.82), with a cut-off at 1.6 cm/m2, therefore the uncorrected diameter was used for further analysis. Uncorrected MPA diameter cut-off at 30 mm with an AUC of 0.85 proved superior to semiquantitative scores for septal stress perfusion (AUC 0.61, P < .0002), wall motion abnormality (P < .0001) and RV hypertrophy (P = .037), although comparison of the latter versus MPA diameter fall short of statistical significance after correction according to Bonferroni (Figure 4 ).
The combined score of all 6 PHT signs (SPECT and CT) resulted in an AUC of 0.85 (0.77-0.93, P<.001) with a cut-off at 2 positive criteria, which yielded a sensitivity, specificity, PPV, NPV, and accuracy of 86%, 74%, 67%, 90%, and 79%, respectively ( Figure 4B ). Thus, the AUC for the combination of SPECT and CT criteria was comparable to MPA diameter alone (0.85). However, specificity and accuracy were superior for MPA diameter alone (Table 3 ).
In 8 patients with documented mild PHT (RV/RA gradient between 30 and 39 mm Hg) MPA diameter was smaller than 3 cm classifying these as false negatives. No false negative results were found in patients with moderate or severe PHT. Only 6 patients had an RV/RA gradient over 60 mm Hg, indicating a severe PHT. The relationship between MPA diameter and PHT is not linear, as it flattens off at higher RV/RA gradients ( Figure 5 ). Therefore, a reliable cut-off value to distinguish severe from nonsevere PHT cannot be obtained.
The visual appreciation of the short-and long-axis SPECT MPI images of observer one resulted in moderate interobserver correlation with a kappa value of 0.533. 28 of the patients with diagnosed Dshape by observer one had a pulmonary hypertension; this resulted in a sensitivity, specificity, positive, and negative predictive value of 76%, 70%, 60%, and 83%, respectively. Relative RV enlargement was found only in 19 patients by observer one and in 25 patients by observer two, what conferred in a poor sensitivity (37%) but high specificity (92%) of observer one, with a positive and negative predictive value of 73% and 71%, respectively, and a slightly higher sensitivity (38%) but lower specificity (82%) by observer two. The inter-observer agreement was fair with a kappa value of 0.362. An overview of all results is given in Table 3 .
Inter-observer analysis of MPA diameter assessment revealed an excellent correlation between the two observers (r = 0.94, P\.001) with narrow Bland-Altman limits of agreement (-3.1 to 3. In the only previous study in which MPA was assessed from unenhanced CT images to evaluate PHT, a cut-off at 33.2 mm was determined yielding a specificity similar to our study but with a much lower sensitivity (58%) 18 . This was probably due-at least in part-to the fact that their slice thickness (10 mm) allowed less accurate measurements of anatomic structures than our CT data with a slice thickness of 2.5 mm.
There is a large body of literature with contrast enhanced CT which has established an MPA diameter exceeding 29 mm as predictor of PHT 19 . This value is slightly below our results, because contrast-enhanced CT provides the luminal diameter while in unenhanced CT the distance of the outer vessel boundaries are measured.
The unenhanced CT scan of this study was performed to obtain attenuation maps for the SPECT MPI and not primarily for diagnostic purposes. Nevertheless, several reports on incidental findings with clinical relevance have stimulated a vivid controversy on whether a systematic readout of unenhanced CT for AC is mandatory for medico legal and ethical aspects or deleterious due to low specificity generating potentially unnecessary harms and costs of further examinations. It is in this setting that the present results are of great potential clinical importance as our MPA cut-off provides an excellent specificity combined with a large AUC to predict PHT, a clinically relevant finding with important implications for perioperative or long-term patient care directly affecting their outcome. Therefore, assessment of MPA diameter from unenhanced CT may be considered as a justifiable added value to SPECT MPI.
It may be perceived as a limitation of this study that echocardiography and CT examinations
were not performed on the same day, as the pulmonary pressure may be subject to changes over time.
However, the fact that despite this potential drawback the AUC was large strengthens our results and may support that MPA enlargement not only reflects acute increase in pulmonary pressure but also represents the result of longterm PHT. In addition, using echocardiography as gold standard for assessing PHT may be less accurate than invasive right heart catheterization. However, this corresponds to daily clinical routine, on which commonly decision making is based. Therefore, it appears justifiable to validate our CT-results against the clinical gold standard echocardiography.
Our results show that the sensitivity of the MPA diameter to predict PHT is not optimal (78%),
suggesting that unenhanced attenuation CT should not be recommended as a first line screening tool for PHT. Another potential limitation is that the assessment of the RV/LV ratio in this study was assessed by use of the average counts in the area with the highest counts, while others have used the maximum count per pixel in this region. However, both methods have been shown to provide interchangeable and equally reproducible results
12
.
Furthermore, the presence of collagen disorders in some of our patients may potentially hamper the generalization of our results, because such patients would be prone to early MPA enlargement at pulmonary pressures in the upper normal range. However, only in two of our patients a a1-antitrypsin deficiency was reported, of whom one was true positive and the other was true negative.
In addition, the image quality of our stand-alone CTscanner may not necessarily be matched by that obtained in Hybrid devices with low end CT scanners.
Finally, the prevalence of pulmonary hypertension in this study population is higher than in the general population referred for SPECT MPI in most centers. However, this selection appears reasonable for such a validation study, to include a sufficient number of patients presenting with the tested pathology, to avoid an artificially high specificity. This would strengthen our results when applied to low prevalence populations. The principle of MPA diameter as a reliable predictor of PHT has been well established for contrast-enhanced CT in large patient cohorts. Although this study extends this to unenhanced low-dose CT the pilot nature limits its power. Therefore, the finding should be interpreted with caution before data from larger studies are available. This is particularly true given that in clinical practice the 4% patients misclassified with possible PHT would likely be referred on having further testing such as echocardiography.
CONCLUSION
The non-contrast-enhanced CT scan can be used to detect PHT, while SPECT MPI parameters are less accurate in detecting PHT. Thus, in patients undergoing SPECT MPI with a CT attenuation scan; this measurement can be reliably performed and may provide useful information about the potential PHT without any additional scans.
Tables:
Figures: Figure 1 . A 63-year-old man with severe chronic obstructive pneumopathy referred for cardiac risk assessment before lung transplantation. Polar plot image of rest wall motion (A), with corresponding semiquantitative scores (B). The QGS scores of the six septal segments are adding up to a total score of 4. , and for the semiquantitative scores for septal wall motion abnormalities (dark blue), septal stress perfusion defects (blue), and right ventricular hypertrophy (light blue). The resulting cut-off for MPA diameter is 30 mm, yielding a sensitivity, specificity, positive, negative predictive value, and an accuracy of 78%, 91%, 83%, 88%, and 86%, respectively. (B) The ROC curve for MPA diameter (red) is compared to the ROC curve for the combined SPECT/CT score (green) (including septal stress perfusion defect and wall motion abnormality, RV hypertrophy, D-shape and RV enlargement, as well as the MPA diameter). The AUC for the combination of SPECT and CT criteria as well as for the MPA alone is identical (0.85), however specificity and accuracy are still higher for the MPA diameter. Figure 5 . There was no linear correlation between pulmonary hypertension (represented by the RV/RA gradient) and MPA diameter, evidenced by the flattening of the curve for higher pressures. To determine a reliable cut-off to distinguish severe from non-severe PHT is in this study population not possible. 
